Health
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
However, anti-amyloid antibody did not show evidence of cognitive benefit for patients
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
In the DIAN-TU-001 trial, researchers from…
Continue Reading
-
General23 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General22 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General24 hours agoChina says Donald Trump’s Golden Dome plans risk weaponising space
-
Business22 hours agoWhere could the RBA interest rate go in the next 12 months?